research Development and validation of a patient‐reported outcome measure for hair loss treatment: The HAIR ‐Q
The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.
Search
for
Sort by
Research
840-870 / 1000+ resultsresearch Development and validation of a patient‐reported outcome measure for hair loss treatment: The
research Introduction
The conclusion is that it's currently unclear if certain rare medical conditions are caused by specific factors due to mostly observational data.
research Corrigendum to “Patients treated for male pattern hair loss with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma” [J. Steroid Biochem. Mol. Biol. 146 (2015) 74–79]
Stopping finasteride for male pattern hair loss changes neuroactive steroid levels in the brain and blood.
research Contents
The document concludes that understanding risks, careful patient selection, precise surgery, quick complication management, and good communication can improve cosmetic facial surgery outcomes.
research American Board of Hair Restoration Surgery – Update
I'm sorry, but I can't provide a summary without the specific details from the document.
research Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.
research Safety update: psychiatric and sexual adverse effects with finasteride
Finasteride can cause depression, suicidal thoughts, and lasting psychiatric and sexual issues.
research SELENIUN1M BLOOD AND HAIR OF HEALTH PERSON FROM NPC HIGH AND LOW RISK AREA OF GUANGDONG PROVINCE
Selenium levels are similar in healthy people from both high and low NPC risk areas.
research Evaluating Participation in Gender-Affirming Care: Cross-Sectional Analysis of Dermatology Program Websites in the United States
Few dermatology programs mention gender-affirming care, highlighting a need for better training and visibility.
research The dermatology consultant: A retrospective analysis of inpatient dermatology
Dermatologists greatly affect inpatient diagnosis and treatment of skin conditions, especially in spotting infections in patients with weakened immune systems.
research Microscope Matters
The document's conclusion cannot be determined as the content is not available for analysis.
research Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ)
The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.
research Report from the Chair of the Media Relations Committee
The document's content couldn't be understood or processed.
research Letter to the Editors
The document's conclusion cannot be summarized because the content is not accessible.
research Chapter 26 Scalp Micropigmentation
I'm sorry, but I can't provide a summary without any specific details from the document.
research What are key challenges for those with polycystic ovary syndrome when interacting with healthcare professionals? A qualitative evidence synthesis
Patients with PCOS face poor communication and support from healthcare professionals.
research An (Ir)reversible Affection of the Sexual Sphere: A Case Report
Finasteride can cause long-lasting sexual dysfunction even after stopping the drug.
research Rose’s Consent & Information on Finasteride and Propecia®
research Clinical Management in Hair Transplant Industry
Many hair transplant patients are unhappy due to clinical mistakes and the need for better training of surgical assistants is crucial.
research Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
Many medications may be linked to cognitive disorders, but most lack warnings on labels.
research How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.
research Abhrs Recognition
The document's conclusion cannot be summarized because the content is not understandable.
research Cultural Sensitivity and Challenges in Management of the Transgender Patient With ESRD in Transplantation
Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.
research The commoditization of surgical hair restoration—a cautionary statement
Prioritizing cost over expertise in hair restoration can lower care quality.
research FINASTERIDA E CALVÍCIE ANDROGENÉTICA: em busca de uma terapêutica embasada na atenção integral à saúde do homem
Finasteride is commonly used for male pattern hair loss but has potential risks, including irreversible sexual dysfunction.
research Diffuse hair loss
The document's conclusion cannot be summarized because it is not readable or understandable.
research Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.
research Knowing the minimal detectable dose can facilitate the interpretation of a hair test result: II. Case example with ibutamoren (MK-677), a growth hormone secretagogue
research Follow-Up of 1 mg Finasteride Treatment of Male Pattern Baldness-Difference between Clinical Trials and Private Office Follow-Up: Influences on Prescribing Habits Evaluated
Finasteride showed limited hair growth and low patient compliance in treating male pattern baldness.